The groundbreaking therapy of the medication represents a major breakthrough in the care of type 2 diabetes. Different to existing therapies, tirzepatide impacts multiple pathways – the GLP-1 hormone and glucose-dependent insulinotropic polypeptide (GIP) – providing improved glucose control and possible weight loss. Researchers are investigatin